ADVANCED BILIARY TRACT CARCINOMA
Clinical trials for ADVANCED BILIARY TRACT CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED BILIARY TRACT CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED BILIARY TRACT CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Triple-Threat treatment trial aims to control aggressive bile duct cancer
Disease control Recruiting nowThis study is testing whether adding a new targeted drug called MP0317 to standard chemotherapy and immunotherapy helps control advanced bile duct cancer better. The trial will include 75 patients who haven't had previous cancer treatments, with 50 receiving the experimental thre…
Matched conditions: ADVANCED BILIARY TRACT CARCINOMA
Phase: PHASE2 • Sponsor: Centre Hospitalier Universitaire de Besancon • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Cancer care comes home: mayo clinic tests house calls for treatment
Disease control Recruiting nowThis study is testing whether giving standard cancer treatments at home is as safe and effective as giving them in a clinic. It aims to see if receiving care at home reduces stress, improves quality of life, and is preferred by patients with advanced cancers. About 220 participan…
Matched conditions: ADVANCED BILIARY TRACT CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Four-Drug attack on tough bile duct cancer
Disease control Recruiting nowThis study is testing a new four-drug combination for people with advanced bile duct cancer that cannot be removed by surgery. All participants will receive the same treatment, which adds two new drugs (adebrelimab and simvastatin) to standard chemotherapy. The main goal is to se…
Matched conditions: ADVANCED BILIARY TRACT CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Could a common drug help cancer patients regain lost weight?
Symptom relief Recruiting nowThis study is testing whether olanzapine, a medication that affects brain chemicals, can help cancer patients who are losing too much weight and have poor appetite. The trial will involve 66 adults with advanced cancers of the stomach, liver, pancreas, colon, or lung who have los…
Matched conditions: ADVANCED BILIARY TRACT CARCINOMA
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Symptom relief
Last updated Apr 01, 2026 14:41 UTC